KD

Kevin Dai

Managing Director at Vivo Capital

San Francisco Bay Area

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Clinical Pharmacy
Hospital Pharmacy
Clinical Pharmacology
Chinese Herbal Medicine
Oncology
Oncology Clinical Research
Integrative Oncology
Pharmacists
Medical Writing
Pharmacy
Biochemistry
Clinical Trials
Financial Modeling
Biotechnology
Pharmaceutical Industry
Healthcare
Life Sciences
Clinical Research
Pharmacology

Education

Lists including Kevin

AH
AE
AF
AJ

Based in SF

3077 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Work Experience

VC
Vivo Capital

2015

  • Managing Director

    2015

CG
Canaccord Genuity Inc.

2014 - 2015

  • Equity Research Associate - Healthcare/Biotechnology

    2014 - 2015

MS
Memorial Sloan-Kettering Cancer Center

2011 - 2014

  • Clinical Oncology Pharmacy Specialist - Hematology/Oncology

    2011 - 2014

Merck

2006 - 2007

  • Research Intern - Biochemistry

    2006 - 2007